Literature DB >> 2910867

Biochemistry of terminal deoxynucleotidyltransferase. Identification and unity of ribo- and deoxyribonucleoside triphosphate binding site in terminal deoxynucleotidyltransferase.

V N Pandey1, M J Modak.   

Abstract

Terminal deoxynucleotidyltransferase is the only DNA polymerase that is strongly inhibited in the presence of ATP. We have labeled calf terminal deoxynucleotidyltransferase with [32P]ATP in order to identify its binding site in terminal deoxynucleotidyltransferase. The specificity of ATP cross-linking to terminal deoxynucleotidyltransferase is shown by the competitive inhibition of the overall cross-linking reaction by deoxynucleoside triphosphates, as well as the ATP analogs Ap4A and Ap5A. Tryptic peptide mapping of [32P]ATP-labeled enzyme revealed a peptide fraction that contained the majority of cross-linked ATP. The properties, chromatographic characteristics, amino acid composition, and sequence analysis of this peptide fraction were identical with those found associated with dTTP cross-linked terminal deoxynucleotidyl-transferase peptide (Pandey, V. N., and Modak, M. J. (1988a). J. Biol. Chem. 263, 3744-3751). The involvement of the same 2 cysteine residues in the crosslinking of both nucleotides further confirmed the unity of the ATP and dTTP binding domain that contains residues 224-237 in the primary amino acid sequence of calf terminal deoxynucleotidyltransferase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910867

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

Review 1.  Terminal deoxynucleotidyl transferase: the story of a misguided DNA polymerase.

Authors:  Edward A Motea; Anthony J Berdis
Journal:  Biochim Biophys Acta       Date:  2009-07-29

2.  Anti-cancer gallotannin penta-O-galloyl-beta-D-glucose is a nanomolar inhibitor of select mammalian DNA polymerases.

Authors:  Yoshiyuki Mizushina; Jinhui Zhang; Angelo Pugliese; Sung-Hoon Kim; Junxuan Lü
Journal:  Biochem Pharmacol       Date:  2010-06-26       Impact factor: 6.100

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.